For reasons that date back to the earliest days of the AIDS epidemic, HIV-positive people with cancer have often been excluded from cancer clinical trials. Now, that may be changing. On Sunday, at the ...

The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa ...

For over a decade, taking a pill like Truvada every day has been the standard of care for HIV prevention efforts. In clinical trials, this type of preventive drug, called pre-exposure prophylaxis ...

A panelist discusses how viral suppression in HIV patients means achieving undetectable virus levels (below 50 or 20 copies per ml), which prevents immune system damage and transmission to others, ...

Our research studies aim to alleviate human suffering as a result of HIV. People around the globe, from doctors to statisticians to community members, are getting involved to make a difference.

The study examined the association of having a consistent HIV health care provider with related clinical outcomes, with an emphasis on a long-term physician-patient relationship. Objectives: Seeking ...

With the dramatic decrease in opportunistic infections brought about by highly active antiretroviral therapy (HAART), [1] the care of patients infected with HIV has largely been transferred to the ...

The George Washington University Vaccine Research Unit in partnership with Scripps Research, IAVI, Fred Hutchinson Cancer Center (FHCC) and the National Institutes of Health, National Institute of ...

You may have heard about Descovy (des-ko'-vee), a medicine approved by the FDA in 2015. Descovy is approved to treat HIV. It can also help prevent people from getting HIV through sex. People with HIV ...

Minister of Health Kim Wilson and Chief Medical Officer Dr. Shaun Ramroop held a press conference today [June 1] to launch ...